• Contact Us
  • Privacy Policy
  • Cookie Privacy Policy
  • DMCA
  • Terms of Use
Monday, July 4, 2022
NEW EXPRESS NEWS
  • HOME
  • US NEWS
  • INDIA
  • EUROPE
  • WORLD
  • GULF NEWS
  • BUSINESS
  • HEALTH
  • RELIGIOUS
  • SPORTS
  • TECHNOLOGY
  • LIFESTYLE
No Result
View All Result
  • HOME
  • US NEWS
  • INDIA
  • EUROPE
  • WORLD
  • GULF NEWS
  • BUSINESS
  • HEALTH
  • RELIGIOUS
  • SPORTS
  • TECHNOLOGY
  • LIFESTYLE
No Result
View All Result
NEW EXPRESS NEWS
No Result
View All Result

USFDA accepts proposed biosimilar application by Mylan, Biocon for review

by NEWS DESK
March 9, 2020
in BUSINESS
0 0
0
0
SHARES
11
VIEWS
ShareShareShareShareShare

USFDA accepts proposed biosimilar application by Mylan, Biocon for review

USFDA accepts proposed biosimilar application by Mylan, Biocon for review
Image Source : TWITTER

USFDA accepts proposed biosimilar application by Mylan, Biocon for review

The US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for a proposed biosimilar to Bevacizumab for review, according to a regulatory filing. The application seeks approval of Bevacizumab for the first-line and second-line treatment of patients with metastatic colorectal cancer in combination with fluorouracil-based chemotherapy, among other related-ailments.

The two firms said that "the US Food and Drug Administration has accepted Mylan's biologics license application (BLA) for MYL-14020, a proposed biosimilar to Avastin (bevacizumab) for review under the 351(k) pathway".

The shares of Biocon were trading at Rs 302.80 a piece on BSE , down 2.26 per cent from the previous close.

Also read: USFDA revokes action against Aurobindo Pharma's Hyderabad unit

Also read: Cipla announces closure of USFDA inspection at Patalganga facility

Previous Post

Gold price today: Gold future slip Rs 73 to Rs 44,085 per 10 gm

Next Post

Sena Slams BJP For Criticising Uddhav Thackeray Over Ayodhya Visit

Related Posts

BUSINESS

Sensex climbs nearly 160 points, Nifty at 15,797 in early trade

July 4, 2022
0
BUSINESS

HDFC and HDFC Bank merger proposal gets nod from stock exchanges

July 3, 2022
0
BUSINESS

Windfall tax to recoup most of Rs 1 lakh crore revenue lost in excise cuts

July 3, 2022
0
BUSINESS

Tesla’s Q2 sales drop amid problems of supply chain, COVID-19 pandemic

July 2, 2022
0
BUSINESS

After terrible first half, 2022 may bring more bad news for US markets

July 2, 2022
0
BUSINESS

Central Government slaps tax on petrol, diesel exports; imposes windfall tax on crude oil

July 1, 2022
0
Next Post

Sena Slams BJP For Criticising Uddhav Thackeray Over Ayodhya Visit

Browse by Category

  • arts and entertainment
  • BUSINESS
  • EDUCATION
  • EUROPE
  • GULF NEWS
  • HEALTH
  • INDIA
  • LIFESTYLE
  • NEWS
  • RELIGIOUS
  • SCIENCE
  • SPORTS
  • TECHNOLOGY
  • Uncategorized
  • US NEWS
  • WORLD
NEW EXPRESS NEWS

Follow Us

  • MALAYALAM NEWS

© 2020 NEW EXPRESS NEWS

  • HOME
  • US NEWS
  • INDIA
  • EUROPE
  • WORLD
  • GULF NEWS
  • BUSINESS
  • HEALTH
  • RELIGIOUS
  • SPORTS
  • TECHNOLOGY
  • LIFESTYLE

© 2020 NEW EXPRESS NEWS

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In